Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion

Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells

(2013) Y.-J. Liang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Siglecs as sensors of self in innate and adaptive immune responses

(2012) James C. Paulson et al.   Annals of the New York Academy of Sciences

The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-  secretion from monocytes/macrophages through the DAP12-Syk pathway

(2012) R. Takamiya et al.   GLYCOBIOLOGY

Investigating Cell Surface Galectin-Mediated Cross-Linking on Glycoengineered Cells

(2012) Brian Belardi et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

A sulfated carbohydrate epitope inhibits axon regeneration after injury

(2012) J. M. Brown et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer

(2011) K. Aalto et al.   BLOOD

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

(2011) Emilie Mamessier et al.   JOURNAL OF CLINICAL INVESTIGATION

Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag

(2011) Jason E. Hudak et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Natural Killer Cells and the Immune Response in Solid Organ Transplantation

(2010) W. Van Der Touw et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Chemical Approaches to Glycobiology

(2010) Laura L. Kiessling et al.   Annual Review of Biochemistry

Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity Engendered by a Kinase-Inactive Human HER2 Adenovirus-Based Vaccination Mediates Resistance to Breast Tumors

(2010) C. Triulzi et al.   CANCER RESEARCH

Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells

(2010) Y. Kawasaki et al.   GLYCOBIOLOGY

Sialylation of 3-Methylcholanthrene-Induced Fibrosarcoma Determines Antitumor Immune Responses during Immunoediting

(2010) M. Cohen et al.   JOURNAL OF IMMUNOLOGY

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes

(2010) Jennifer A. Belisle et al.   Molecular Cancer

Sialylated multivalent antigens engage CD22in transand inhibit B cell activation

(2009) Adam H. Courtney et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future

(2008) Marc Daëron et al.   IMMUNOLOGICAL REVIEWS

Noncovalent Cell Surface Engineering: Incorporation of Bioactive Synthetic Glycopolymers into Cellular Membranes

(2008) David Rabuka et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Natural killer cell–directed therapies: moving from unexpected results to successful strategies

(2008) Magali Terme et al.   NATURE IMMUNOLOGY

Up on the tightrope: natural killer cell activation and inhibition

(2008) Lewis L Lanier   NATURE IMMUNOLOGY

NK cells and cancer immunosurveillance

(2008) I Waldhauer et al.   ONCOGENE

Xenotransplantation: Role of natural immunity

(2008) Shengqiao Li et al.   TRANSPLANT IMMUNOLOGY